Gaztransport et Technigaz (0QT5)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 202.60 |
|---|---|
| 52-week range | 154.00 – 227.00 |
| Return, 1 month / 3 months | −9.7% / +4.0% |
| Return, 1 year / 3 years | +27.7% / +101.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 23.0% |
| Worst drawdown (1 year) | -14.1% |
| Average daily value traded | 2.91M EUR |
| Dividend yield | 4.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gaztransport et Technigaz designs membrane containment systems used to carry and store liquefied natural gas aboard ships and in onshore tanks. The company licenses its technologies to shipyards and engineering firms, which build the vessels and facilities, and it earns royalties from those licences. It also provides related engineering and support services to shipowners and operators. The business is based in France and serves the international gas shipping and energy infrastructure markets.
On this site Gaztransport et Technigaz appears as a stock on the London Exchange (UK), code 0QT5, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gaztransport et Technigaz (0QT5) trades on the London Exchange in UK. It last closed at EUR 202.60 on 23 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 371 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.7% and over the last three months it rose 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.3% | ||
| From 52-week high | -10.0% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.0% | ||
| 6-month return | 2.4% | ||
| 12-month return, skipping the last month | 41.4% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.1% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.91M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.4% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.3% |
|---|---|
| 1 month | −9.7% |
| 3 months | +4.0% |
| 6 months | +2.4% |
| 1 year | +27.7% |
| 3 years | +101.3% |
| 5 years | +249.6% |
Signals
| 50-day / 200-day average | 213.21 / 196.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.66 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jun 2026 | EUR 4.9400 |
| 9 Dec 2025 | EUR 4.0000 |
| 17 Jun 2025 | EUR 3.8300 |
| 10 Dec 2024 | EUR 3.6700 |
| 18 Jun 2024 | EUR 2.5100 |
| 12 Dec 2023 | EUR 1.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.